mezlocillin
| SMILES | CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCN(C3=O)S(C)(=O)=O)C3=CC=CC=C3)C(=O)N2[C@H]1C(O)=O |
| InChIKey | YPBATNHYBCGSSN-VWPFQQQWSA-N |
Chemical properties
| Hydrogen bond acceptors | 8 |
| Hydrogen bond donors | 3 |
| Rotatable bonds | 6 |
| Molecular weight (Da) | 539.1 |
Drug properties
| Molecular type | Small molecule |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| CB2 | CNR2 | Human | Cannabinoid | A | pKi | 8.38 | 8.38 | 8.38 | Drug Central |
| DP1 | PD2R | Human | Prostanoid | A | pKi | 8.31 | 8.31 | 8.31 | Drug Central |
| DP2 | PD2R2 | Human | Prostanoid | A | pKi | 8.2 | 8.2 | 8.2 | Drug Central |
| EP1 | PE2R1 | Human | Prostanoid | A | pKi | 8.36 | 8.36 | 8.36 | Drug Central |
| EP2 | PE2R2 | Human | Prostanoid | A | pKi | 8.18 | 8.18 | 8.18 | Drug Central |
| EP3 | PE2R3 | Human | Prostanoid | A | pKi | 8.36 | 8.36 | 8.36 | Drug Central |
| EP4 | PE2R4 | Human | Prostanoid | A | pKi | 8.36 | 8.36 | 8.36 | Drug Central |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| CB1 | CNR1 | Human | Cannabinoid | A | pIC50 | 8.4 | 8.4 | 8.4 | Drug Central |
| A3 | AA3R | Human | Adenosine | A | pIC50 | 8.31 | 8.31 | 8.31 | Drug Central |